These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 28739873)

  • 1. Growth-incompetent monomers of human calcitonin lead to a noncanonical direct relationship between peptide concentration and aggregation lag time.
    Kamgar-Parsi K; Hong L; Naito A; Brooks CL; Ramamoorthy A
    J Biol Chem; 2017 Sep; 292(36):14963-14976. PubMed ID: 28739873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of aromatic residues in amyloid fibril formation of human calcitonin by solid-state 13C NMR and molecular dynamics simulation.
    Itoh-Watanabe H; Kamihira-Ishijima M; Javkhlantugs N; Inoue R; Itoh Y; Endo H; Tuzi S; Saitô H; Ueda K; Naito A
    Phys Chem Chem Phys; 2013 Jun; 15(23):8890-901. PubMed ID: 23552643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural Perturbation of Monomers Determines the Amyloid Aggregation Propensity of Calcitonin Variants.
    Liu Y; Wang Y; Zhang Y; Zou Y; Wei G; Ding F; Sun Y
    J Chem Inf Model; 2023 Jan; 63(1):308-320. PubMed ID: 36456917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Insights into the Effects of F16L and F19L Substitutions on the Conformation and Aggregation Dynamics of Human Calcitonin.
    Huang F; Huang J; Yan J; Liu Y; Lian J; Sun Q; Ding F; Sun Y
    J Chem Inf Model; 2024 Jun; 64(11):4500-4510. PubMed ID: 38745385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Converting the highly amyloidogenic human calcitonin into a powerful fibril inhibitor by three-dimensional structure homology with a non-amyloidogenic analogue.
    Andreotti G; Vitale RM; Avidan-Shpalter C; Amodeo P; Gazit E; Motta A
    J Biol Chem; 2011 Jan; 286(4):2707-18. PubMed ID: 21078667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlling the self-assembly of human calcitonin: a theoretical approach using molecular dynamics simulations.
    Paul S; Paul S
    Phys Chem Chem Phys; 2021 Jul; 23(26):14496-14510. PubMed ID: 34184696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How Glycosaminoglycans Promote Fibrillation of Salmon Calcitonin.
    Malmos KG; Bjerring M; Jessen CM; Nielsen EH; Poulsen ET; Christiansen G; Vosegaard T; Skrydstrup T; Enghild JJ; Pedersen JS; Otzen DE
    J Biol Chem; 2016 Aug; 291(32):16849-62. PubMed ID: 27281819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibiting Human Calcitonin Fibril Formation with Its Most Relevant Aggregation-Resistant Analog.
    Chen YT; Hu KW; Huang BJ; Lai CH; Tu LH
    J Phys Chem B; 2019 Dec; 123(48):10171-10180. PubMed ID: 31692350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conformational transitions and fibrillation mechanism of human calcitonin as studied by high-resolution solid-state 13C NMR.
    Kamihira M; Naito A; Tuzi S; Nosaka AY; Saitô H
    Protein Sci; 2000 May; 9(5):867-77. PubMed ID: 10850796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of disulfide bond and cholesterol derivatives on human calcitonin amyloid formation.
    Lantz R; Busbee B; Wojcikiewicz EP; Du D
    Biopolymers; 2020 May; 111(5):e23343. PubMed ID: 31804717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulating calcitonin fibrillogenesis: an antiparallel alpha-helical dimer inhibits fibrillation of salmon calcitonin.
    Andreotti G; Motta A
    J Biol Chem; 2004 Feb; 279(8):6364-70. PubMed ID: 14594801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Existence of different structural intermediates on the fibrillation pathway of human serum albumin.
    Juárez J; Taboada P; Mosquera V
    Biophys J; 2009 Mar; 96(6):2353-70. PubMed ID: 19289061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early stages of salmon calcitonin aggregation: effect induced by ageing and oxidation processes in water and in the presence of model membranes.
    Gaudiano MC; Colone M; Bombelli C; Chistolini P; Valvo L; Diociaiuti M
    Biochim Biophys Acta; 2005 Jun; 1750(2):134-45. PubMed ID: 15964788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of key components in the irreversibility of salmon calcitonin binding to calcitonin receptors.
    Hilton JM; Dowton M; Houssami S; Sexton PM
    J Endocrinol; 2000 Jul; 166(1):213-26. PubMed ID: 10856900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unraveling the underlying mechanisms of reduced amyloidogenic properties in human calcitonin via double mutations.
    Chang YP; Pan PC; Tu LH
    Protein Sci; 2024 Apr; 33(4):e4952. PubMed ID: 38501491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NMR characterization of monomeric and oligomeric conformations of human calcitonin and its interaction with EGCG.
    Huang R; Vivekanandan S; Brender JR; Abe Y; Naito A; Ramamoorthy A
    J Mol Biol; 2012 Feb; 416(1):108-20. PubMed ID: 22200484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tyrosine 12 of human calcitonin modulates its amyloid formation, membrane binding, and bioactivity.
    Hsieh IC; Chen TW; Chuang YP; Lai YJ; Tu LH
    Biochimie; 2022 Jun; 197():121-129. PubMed ID: 35240220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of human and salmon calcitonin secondary structure in solutions with low dielectric constants.
    Arvinte T; Drake AF
    J Biol Chem; 1993 Mar; 268(9):6408-14. PubMed ID: 8454613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A dimer model of human calcitonin13-32 forms an α-helical structure and robustly aggregates in 50% aqueous 2,2,2-trifluoroethanol solution.
    Kawashima H; Katayama M; Yoshida R; Akaji K; Asano A; Doi M
    J Pept Sci; 2016 Jul; 22(7):480-4. PubMed ID: 27238594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the spherical intermediates and fibril formation of hCT in HEPES solution using solid-state 13C-NMR and transmission electron microscopy.
    Itoh-Watanabe H; Kamihira-Ishijima M; Kawamura I; Kondoh M; Nakakoshi M; Sato M; Naito A
    Phys Chem Chem Phys; 2013 Oct; 15(39):16956-64. PubMed ID: 24002168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.